BioSpace News Archive

CommScope and SwIFT Consortium Research Reveals Optimistic Future for Network Operators

New fibre optic switching technologies could potentially automate manual processes and reduce energy costs across telecommunications, according to the study.

December 4, 2017

·

4 min read

Business

Aerie Announces Appointment of Heather Johnson as Regional Sales Director for the Northeast Region

Aerie’s Vice President of Sales. Ms. Johnson will direct the activities of the Company’s district sales managers and territory managers in the Northeastern region of the United States, focused on execution of Aerie’s sales strategies.

December 4, 2017

·

5 min read

Business

Exscientia Opens New Office in Oxford as Part of Plan for Rapid Growth and Expansion

Exscientia, the leading AI-driven drug discovery company, is delighted to announce the opening of its new offices in central Oxford, UK, in the UK’s most dynamic life science cluster.

December 4, 2017

·

1 min read

Business

Summit Therapeutics: Notice of Third Quarter Results

The company will announce its financial results for the third quarter and nine months ended 31 October 2017 on 6 December 2017.

December 4, 2017

·

1 min read

Resverlogix Closes Previously Announced $87M Private Placement With Shenzhen Hepalink

Each full warrant is exercisable at a price of $1.64 per share for a period of four years from the closing of the offering.

December 4, 2017

·

3 min read

Drug Development

Bayer Release: Updated Larotrectinib Pediatric Phase I Clinical Trial Data Demonstrates Response in TRK Fusion Cancers

These data are being presented today at the AACR Special Conference on Pediatric Cancer Research in Atlanta.

December 4, 2017

·

4 min read

Business

Acentrus Specialty Signs New Agreement With Pfizer Oncology

Pfizer is the first supplier that has been extended an agreement for its limited distribution drug portfolio of oral oncolytics by Acentrus.

December 4, 2017

·

2 min read

Valeant Pharma and One of its Subsidiaries Commence Cash Tender Offers for Up to $1,000,000,000 Outstanding Principal Amount

Valeant is the Offeror for the notes issued by it, and VPI is the Offeror for the notes issued by it.

December 4, 2017

·

12 min read

Drug Development

Ovid Therapeutics Presents New Data Demonstrating Potential of TAK-935/OV935 as a Novel Treatment for Developmental and Epileptic Encephalopathies at the American Epilepsy Society (AES) Annual Meeting

The data were presented at the American Epilepsy Society 71st Annual Meeting, taking place December 1-5, 2017, at the Walter E. Washington Convention Center in Washington, D.C.

December 4, 2017

·

10 min read

Business

Kraig Biocraft Laboratories Expands Team With Appointment of New Molecular Biologist

Over the next 60 days the Company plans to hire additional research staff to support this role as the Company rapidly ramps up development of new and stronger transgenics and polymers.

December 4, 2017

·

2 min read